Company profileNutraceutical & supplements#549 of 1,318 in Pakistan✓ No DRAP alerts

Samarkand Laboratories, Faisalabad

Nutraceutical & supplement manufacturer · 23 registered products

Ranked #27 of 35 companies in Anti-Acne Preparations

23 registered products 2 distinct molecules 0 DRAP alerts
23 of this company's registrations sit in the DRAP category “Nutritional Supplement / Multivitamin”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

23
registered products
2
distinct molecules
1
therapeutic classes
0
DRAP alerts

Samarkand Laboratories, Faisalabad is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 23 product registrations. Its portfolio is concentrated in Anti-Acne Preparations. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Samarkand

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Nutritional Supplement / Multivitamin23 brands

Therapeutic classes

Anti-Acne Preparations · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 294.12 – Rs 294.12
Median across source: Rs 294.12

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.1 shared molecules
SHAWAN PHARMACEUTICALS1 shared molecules
GSK Pakistan Limited1 shared molecules
TABROS PHARMA (PVT). LTD.1 shared molecules
CRYSTOLITE PHARMACEUTICALS1 shared molecules
VALOR PHARMACEUTICALS1 shared molecules
SHROOQ PHARMACEUTICALS1 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 139 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
GENOME PHARMACEUTICALS (PVT) LTD holds 113 molecules not in this portfolio
AcitretinAmlodipineAnastrazoleAnastrozoleAprepitantArtemether

Get the full profile for Samarkand

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.